Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Multiple myeloma and updated the revision to v3.0.2; removed the old revision note (v3.0.1) and the Back to Top link.
    Difference
    0.4%
    Check dated 2025-09-14T18:53:58.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the section on Multiple myeloma from MedlinePlus Genetics has been deleted.
    Difference
    0.4%
    Check dated 2025-09-07T13:40:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new medical terms related to plasma cell myeloma and various compounds. Notably, several previous terms and references related to multiple myeloma and specific drugs have been removed.
    Difference
    3%
    Check dated 2025-08-31T11:37:08.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:37:28.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T23:58:06.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed. This indicates a transition to a newer version while eliminating previous notifications about service interruptions.
    Difference
    1.0%
    Check dated 2025-08-02T18:19:39.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.